Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase 1 trial evaluating cellular adoptive immunotherapy in patients with relapsed or refractory follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Cellular Adoptive Immunotherapy

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lymphoma | Phase 1 | Status: COMPLETED